Opinion statement
Placental site trophoblastic tumor (PSTT) is the least common and the most ambiguous gestational trophoblastic tumor. Presentation of PSTT may occur in the course of gestation or from 1 week to 14 years after a normal or an abnormal pregnancy (mole, ectopic pregnancy, abortion). The indicators of aggressive behavior for this tumor are not well established. Due to the rarity of this disease that usually affects women of childbearing potential, we aimed to review the current literature, to identify risk factors and the best conservative therapeutic choices among the cases described. We performed a systematic literature search of articles in English language, published from 1996 to 2017 and indexed in PubMed and Scopus. Based on selective inclusion/exclusion criteria, we considered eight papers eligible for the review. Five were case reports and three were retrospective studies. We extracted and organized data into three different categories depending on the main treatment used. A total of 12 cases were treated with laparotomy; in 5 cases, the treatment was not curative. Therefore, a total abdominal hysterectomy was needed. Five cases were treated successfully with a minimally invasive approach, 2 with uterine evacuation, 2 with hysteroscopic resection, and 1 with a combined hysteroscopic/laparoscopic resection. Only 1 case treated with exclusive chemotherapy proved curative for the patient. Preservation of fertility in PSTT patients of childbearing age should be considered and as showed by the abovementioned studies, is a possible and safe therapeutic choice. Laparotomy for local uterine resection with the modified Strassman approach could be offered in patients at clinical stage 1 that are very motivated to retain fertility, extensively informing the patient of the risks and benefits related to this choice.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
Kurman RJ. The morphology, biology and pathology of intermediate trophoblast: a look back to the present (review). Hum Pathol. 1991;22:847–55.
Lan C, Li Y, He J, Liu J. Placental site trophoblastic tumor: lymphatic spread and possible target markers. Gynecol Oncol. 2010;116(3):430–7.
Shih IM, Kurman RJ. The pathology of intermediate trophoblastic tumors and tumor-like lesions. Int J Gynecol Pathol. 2001;20(1):31–47.
•• Santoro G, Laganà AS, Micali A, Barresi V, Giacobbe V, Palmara V. Historical, morphological and clinical overview of placental site trophoblastic tumors: from bench to bedside. Arch Gynecol Obstet. 2017;295(1):173–87. The number of cases described in literature was updated, and a model (PSTT model) that collects and unifies PSTT evidences as this would be useful to identify worldwide precise prognostic factors (which are still lacking) was suggested.
Dessau R, Rustin GJS, Dent J, Paradinas FJ, Bagshawe KD. Surgery and chemotherapy in the management of placental site tumor. Gynecol Oncol. 1990;39:56–9.
Scully RE, Young RH. Trophoblastic pseudotumor: a reappraisal. Am J Surg Pathol. 1981;5(1):75–6.
Finkler NJ. Placental site trophoblastic tumor. Diagnosis, clinical behavior and treatment. J Reprod Med. 1991;36(1):27–30.
Schmid P, Nagai Y, Agarwal R, Hancock B, Savage PM, Sebire NJ, et al. Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study. Lancet. 2009;374(9683):48–55.
Kurman RJ, Young RH, Norris HJ. Immunocytochemical localization of placental lactogen and chorionic gonadotropin in the normal placenta and trophoblastic tumors, with emphasis on intermediate trophoblast and the placental site trophoblastic tumor. Int J Gynecol Pathol. 1984;3:101–21.
Sakamoto C, Oikawa K, Kashimura M, Egashira K. Sonographic appearance of placental site trophoblastic tumor. J Ultrasound Med. 1990;9:533–5.
Caspi B, Elchalal U, Dgani R, Ben-Hur H, Rozenman D, Nissim F. Invasive mole and placental site trophoblastic tumor. Two entities of gestational trophoblastic disease with a common ultrasonographic appearance. J Ultrasound Med. 1991;10(9):517–9.
Abulafia O, Sherer DM, Fultz PJ, Sternberg LB, Angel C. Unusual endovaginal ultrasonography and magnetic resonance imaging of placental site trophoblastic tumor. Am J Obstet Gynecol. 1994;170(3):750–2.
Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, et al. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi39–50.
Leiserowitz GS, Webb MJ. Treatment of placental site trophoblastic tumor with hysterotomy and uterine reconstruction. Obstet Gynecol. 1996;88(4 Pt 2):696–9.
Tsuji Y, Tsubamoto H, Hori M, Ogasawara T, Koyama K. Case of PSTT treated with chemotherapy followed by open uterine tumor resection to preserve fertility. Gynecol Oncol. 2002;87(3):303–7.
Machtinger R, Gotlieb WH, Korach J, Fridman E, Apter S, Goldenberg M, et al. Placental site trophoblastic tumor: outcome of five cases including fertility preserving management. Gynecol Oncol. 2005;96(1):56–61.
Pfeffer PE, Sebire N, Lindsay I, McIndoe A, Lim A, Seckl MJ. Fertility-sparing partial hysterectomy for placental-site trophoblastic tumour. Lancet Oncol. 2007;8(8):744–6.
Liszka L, Wilk M, Wodolazski A, Palen P, Sikora J. Successful treatment of placental site trophoblastic tumor in twin pregnancy without hysterectomy. Tumori. 2009;95(1):108–11.
Saso S, Haddad J, Ellis P, Lindsay I, Sebire NJ, McIndoe A, Seckl MJ, Smith JR. Placental site trophoblastic tumours and the concept of fertility preservation. BJOG 2012;119(3):369–374; discussion 374.
Shen X, Xiang Y, Guo L, Feng F, Wan X, Xiao Y, et al. Fertility-preserving treatment in young patients with placental site trophoblastic tumors. Int J Gynecol Cancer. 2012;22(5):869–74.
Ashton E, Szutowska M, Shafer A, Hoffman J. Attempted conservative management of a placental site trophoblastic tumor: a case report. Conn Med. 2014;78(8):475–7.
Numnum TM, Kilgore LC, Conner MG, Straughn JM Jr. Fertility sparing therapy in a patient with placental site trophoblastic tumor: a case report. Gynecol Oncol. 2006;103(3):1141–3.
Tse KY, Ngan HY. Gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2012;26(3):357–70.
Jensen AK, Macklon KT, Fedder J, Ernst E, Humaidan P, Andersen CY. 86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children. J Assist Reprod Genet. 2017;34(3):325–36.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Benito Chiofalo, Vittorio Palmara, Antonio Simone Laganà, Onofrio Triolo, Salvatore Giovanni Vitale, Francesca Conway, and Giuseppe Santoro declare they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Gynecologic Cancers
Rights and permissions
About this article
Cite this article
Chiofalo, B., Palmara, V., Laganà, A.S. et al. Fertility Sparing Strategies in Patients Affected by Placental Site Trophoblastic Tumor. Curr. Treat. Options in Oncol. 18, 58 (2017). https://doi.org/10.1007/s11864-017-0502-0
Published:
DOI: https://doi.org/10.1007/s11864-017-0502-0